Tom Cusack
Fortuna: 1 011 $ al 30/06/2026
Fortuna: 1 011 $ al 30/06/2026
Thomas Patrick Cusack is currently Managing Director at Starboard Value LP since 2017 and Independent Director at Heron Therapeutics, Inc. starting in 2025.
Former positions include Analyst at Lehman Brothers Holdings, Inc. in 2008 and Associate at Barclays Capital, Inc. in 2011.
Education includes undergraduate studies at The Leonard N Stern School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/04/2026 | 2.367 ( 0 % ) | 1 011 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HERON THERAPEUTICS, INC. | Director/Miembro de la Junta | 27/10/2025 |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value invests primarily, although not exclusively, in the securities of US public companies they believe are deeply undervalued by the marketplace and likely to experience a significant appreciation in value as a result of operational improvements or a change in ownership, corporate direction or management or improved corporate governance. The firm typically conducts a thorough analysis of management, capital structure and corporate governance related issues, valuing the company using a traditional, fundamental, and value-based approach. Starboard Value is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Analyst-Equity | 01/01/2011 |
| Empresas | Cargo | Fin |
|---|---|---|
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Corporate Officer/Principal | 30/09/2008 |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 31/05/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value invests primarily, although not exclusively, in the securities of US public companies they believe are deeply undervalued by the marketplace and likely to experience a significant appreciation in value as a result of operational improvements or a change in ownership, corporate direction or management or improved corporate governance. The firm typically conducts a thorough analysis of management, capital structure and corporate governance related issues, valuing the company using a traditional, fundamental, and value-based approach. Starboard Value is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.